Communicable disease threats report, 19-25 September, week 39
September 26, 2026
Combined indicator: 14-day notification rate, testing rate and test positivity, updated 7 October 2021, weeks 38-39
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU
14-day case notification rate per 100 000 inhabitants, updated 23 September 2021, weeks 38-39
Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU
Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2, version 1.0
Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2, version 1.0.
Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 65 years and older, ECDC multi-country study
This document reports the first interim pooled estimates from the ECDC study of COVID-19 vaccine effectiveness (VE).
ECDC builds study infrastructure to monitor COVID-19 vaccine effectiveness
ECDC is creating new infrastructure to allow for regular monitoring and analysis of COVID-19 vaccine effectiveness (VE) over time, using a multi-country approach, through the implementation of studies in different settings.
Communicable disease threats report, 3-9 October 2021, week 40
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 October 2021 and includes updates on COVID-19, West Nile virus, polio and MERS-CoV.
High risk of autumn surge in COVID-19 cases and deaths in countries with insufficient vaccination coverage, warns ECDC
EU/EEA countries that have not yet achieved high enough COVID-19 vaccination coverage in their total populations, which are planning to relax non-pharmaceutical interventions during the next two weeks, run a high risk of experiencing a significant surge of cases, hospitalisations and mortality from now until the end of November.
